Contacts, documents and full notice history are available with a subscription.
Special Notice Expired 1 notice 2 documents

6505--Notice of Intent - Sole Source for Pluvicto 36C26125Q0797

Solicitation 36C26125Q0797 Copied Notice ID 73720f27fac847c5aee959594aa5e8c6 Copied VETERANS AFFAIRS, DEPARTMENT OF — 261-NETWORK CONTRACT OFFICE 21 (36C261)
SAM.gov
Posted
Sep 16, 2025
Deadline
Sep 19, 2025
Set-aside
None
NAICS
325412
PSC
6505

Summary

AI-generated · Sep 17, 2025

The VA intends to award a sole-source, firm-fixed-price delivery order to Novartis Pharmaceuticals Corporation for Pluvicto (Lutetium-177 Vipivotide Tetraxetan), a highly specialized radiopharmaceutical used to treat adult PSMA-positive metastatic castration-resistant prostate cancer after AR pathway inhibition and taxane-based chemotherapy. Pluvicto is FDA-approved and manufactured under Novartis as a trademark; this action supports care for the VA Northern California Health Care System.

Not a request for competitive proposals. Interested parties may submit written notices with evidence of capability by 5:00 pm PDT on 09/17/2025 to victoria.torres@va.gov; supporting information must be provided at no cost to the Government. The Government will consider responses, but the decision to pursue competition in the future remains at its discretion. Inquiries should be emailed to the same address; no telephone requests. Responses should demonstrate clear and convincing evidence that competition would be advantageous to the Government in future procurements.

Department of Veterans Affairs (VA), Regional Procurement Office West (RPOW), Network Contracting Office (NCO) 21, on behalf of Veterans Integrated Service Network (VISN) 21 intends to award a sole source, firm-fixed-price delivery order to Novartis Pharmaceuticals Corporation 59 Route 10, East Hanover, NJ 07936, for the purchase of Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan). The associated North America Classification Systems (NAICS) Code is 325412, Pharmaceutical Preparation Manufacturing. The VA Northern California Health Care System, 10535 Hospital Way, Mather, CA 95655, has a requirement for the purchase of Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan). Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan) is a highly specialized radiopharmaceutical. Pluvicto is a radiologic therapeutic agent indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy. Per the FDA website https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm. Pluvicto is an FDA approved drug. Pluvicto manufactured and is a trademark of Novartis Pharmaceuticals Corporation. This notice satisfies the requirement at FAR 5.201(b)(1), to publicize the proposed contract action. This notice of intent is not a request for competitive proposals. Interested parties may give written notice to victoria.torres@va.gov by 5:00pm PDT on 09/17/2025. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government. Responses will be considered by the Government; however, a determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government. Inquiries shall be emailed to victoria.torres@va.gov. No telephone requests will be accepted. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government in future procurements.

From Special Notice posted on Sep 16, 2025

Notice history

1
  1. Special Notice LATEST Posted Sep 16, 2025 View

Details

Solicitation number 36C26125Q0797
Notice ID 73720f27fac847c5aee959594aa5e8c6
Notice type Special Notice
Product / Service (PSC) 6505
NAICS 325412
Place of performance Mather, California
Archive date Oct 04, 2025

Award Information

Not yet awarded

Contacts

primary
VICTORIA TORRES

Email

Agency

VETERANS AFFAIRS, DEPARTMENT OF
VETERANS AFFAIRS, DEPARTMENT OF
261-NETWORK CONTRACT OFFICE 21 (36C261)

Place of Performance

Mather, California 95655
USA

Dates

Posted Sep 16, 2025 10 months ago
Last Updated Aug 06, 2026 1 day ago
Due Sep 19, 2025 10 months ago